scispace - formally typeset
J

Jinjun Shi

Researcher at Brigham and Women's Hospital

Publications -  135
Citations -  17055

Jinjun Shi is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Small interfering RNA & Cancer. The author has an hindex of 50, co-authored 126 publications receiving 12872 citations. Previous affiliations of Jinjun Shi include Texas A&M University & Massachusetts Institute of Technology.

Papers
More filters
Journal ArticleDOI

Cancer nanomedicine: progress, challenges and opportunities.

TL;DR: Novel engineering approaches are discussed that capitalize on the growing understanding of tumour biology and nano–bio interactions to develop more effective nanotherapeutics for cancer patients.
Journal ArticleDOI

Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications

TL;DR: Two important aspects of nanomedicine, drug delivery and tissue engineering are discussed, highlighting the advances the authors have recently experienced, the challenges they are currently facing, and what they are likely to witness in the near future.
Journal ArticleDOI

Black Phosphorus Nanosheets as a Robust Delivery Platform for Cancer Theranostics.

TL;DR: A triple-response combined therapy strategy is achieved by PEGylated BP nanosheets, showing a promising and enhanced antitumor effect.
Journal ArticleDOI

Insight into nanoparticle cellular uptake and intracellular targeting

TL;DR: An account of ligand-targeted nanoparticles for receptor-mediated cellular internalization as a strategy for modulating the cellular uptake of nanoparticles is presented and prospects, potential, and concrete expectations from the field of targeted nanomedicines and strategies to meet those expectations are provided.
Journal ArticleDOI

Antimonene Quantum Dots: Synthesis and Application as Near-Infrared Photothermal Agents for Effective Cancer Therapy

TL;DR: A new generation of PTAs based on two-dimensional (2D) antimonene quantum dots (AMQDs) was developed by a novel liquid exfoliation method that demonstrated notable NIR-induced tumor ablation ability and biocompatibility and stability in physiological medium.